Further studies will be needed to elaborate whether CSF derived bioactive tau seeds might be of use as a marker of AD, as well as to study mechanistic aspects of potentially strain specific patterns of CSF bioseeds in different tauopathies. Here, MAPT is linked to Alzheimer disease.